-
Tropisetron Hydrochloride: Assay Workflow Guide
2026-09-15
Tropisetron Hydrochloride enables controlled interrogation of 5-HT3 receptor signaling while also supporting α7-nicotinic receptor and renal transporter studies. This workflow guide shows how to separate receptor pharmacology from OCT2/MATE1 effects, select practical assay conditions, and troubleshoot solvent, timing, and interpretation issues.
-
Novobiocin Workflows for Synergy and Resistance
2026-09-15
Novobiocin combines aminocoumarin antibacterial activity with Hsp90-directed effects, making it useful for mechanism-led bacterial, antiparasitic, and antiviral workflows. This guide translates a validated synergy-testing framework into practical concentration planning, orthogonal readouts, and troubleshooting strategies.
-
Berberine, RXRα/PPARγ, and SASP in Atherosclerosis
2026-09-14
A 2025 study identifies an RXRα/PPARγ/NEDD4 signaling axis through which berberine suppresses senescence-associated secretory phenotype inflammation in macrophage-derived foam cells and atherosclerotic plaques. Its combination of ApoE−/− mouse experiments, foam-cell models, Smart-seq profiling, and macrophage-specific RXRα knockdown provides a mechanistic framework for linking nuclear-receptor activity to ubiquitin-dependent regulation of the GATA4/p62 complex.
-
Wild and Cultivated Taihangia rupestris: Bioactivity
2026-09-14
This 2026 RSC Advances study integrates UPLC-MS/MS, multiple antioxidant assays, α-glucosidase inhibition, active-compound screening, and molecular docking to compare wild and cultivated Taihangia rupestris leaves. Foothill cultivation produced the strongest antioxidant and enzyme-inhibitory profiles, supporting sustainable sourcing while identifying flavonoids and phenolics for further antidiabetic research.
-
Anti-ROR1 Antibody: A Causal Assay Framework
2026-09-13
Anti-ROR1 Antibody (Zilovertamab) can be evaluated through a staged evidence framework that separates binding, receptor presentation, pathway modulation, and phenotype. This article also shows how causal assay logic from DON hepatotoxicity research can improve cancer research without conflating the two biological systems.
-
WY-14643 (Pirinixic Acid): Assay Reliability
2026-09-12
A scenario-driven guide to using WY-14643 (Pirinixic Acid), SKU A4305, in viability, proliferation, cytotoxicity, metabolic, and inflammation workflows. It connects product specifications with practical controls, solubility management, interpretation limits, and evidence from PPARα-focused research.
-
Tianyu Formulation and Pyroptosis in Rheumatoid Arthritis
2026-09-12
This 2026 FASEB Journal study investigated how the multicomponent Tianyu formulation affects rheumatoid arthritis fibroblast-like synovial cells and collagen-induced arthritis in rats. Its central contribution is the integration of cellular, animal, chemical-profiling, and docking evidence linking treatment responses to suppression of the NLRP3/Caspase-1/GSDMD pyroptosis axis.
-
Sulfamonomethoxine Toxicity Across Aquatic Species
2026-09-11
Huang and colleagues evaluated sulfamonomethoxine toxicity across algae, cladocerans, and medaka, combining acute and chronic bioassays to compare sensitivity across aquatic taxa. The study identified microalgae as the most sensitive tested group and provides a useful framework for interpreting antibiotic residues in aquaculture-related waters.
-
Methyl-β-cyclodextrin: Membrane Workflow Guide
2026-09-11
Methyl-β-cyclodextrin (MβCD) supports controlled membrane cholesterol extraction and related studies of lipid organization, membrane fluidity modulation, and cholesterol-dependent signaling. It is intended for controlled scientific research workflows only, not diagnostic, clinical, or therapeutic use, and working conditions should be optimized with appropriate cell and vehicle controls.
-
HMGB1 Exosomes in Lupus Nephritis Endothelial Injury
2026-09-10
The reference study identifies podocyte-derived exosomal HMGB1 as a mediator of glomerular endothelial cell injury in lupus nephritis, acting partly through TRIM27 upregulation. Its combination of patient material, lupus-like mice, donor–recipient cell assays, vesicle perturbation, and genetic manipulation provides a useful framework for testing exosome-dependent kidney injury mechanisms.
-
Ridaforolimus Workflows for mTOR Research
2026-09-10
Ridaforolimus, also called Deforolimus or MK-8669, enables low-nanomolar interrogation of mTOR signaling across proliferation, VEGF production, and senescence-related assay systems. This practical guide connects pathway engagement with cancer-cell phenotyping, angiogenesis inhibition, and machine-learning-informed compound validation.
-
Carbenoxolone disodium: Practical Lab Guide
2026-09-09
Carbenoxolone disodium is an exploratory 11β-hydroxysteroid dehydrogenase inhibitor for controlled studies of glucocorticoid access, corticosterone metabolism, and gap junction communication. It is best used in enzyme, cell, or tissue workflows with matched vehicle and orthogonal controls, rather than as a selective target-validation reagent or stand-alone in vivo efficacy treatment.
-
N4-Acetylcytidine: Assays, Workflows & Tips
2026-09-09
N4-Acetylcytidine enables controlled studies of free ac4C nucleoside metabolism, while structural evidence helps researchers distinguish nucleotide turnover from modification removal in RNA. This guide translates that distinction into practical enzyme assays, RNA comparison workflows, controls, and troubleshooting strategies.
-
Multiomics Maps Acute Liver Injury Drug Responses
2026-09-08
The reference study combines co-expression network analysis with transcriptomic and proteomic profiling to compare how bifendate and muaddil sapra affect acute liver injury. Its key contribution is a systems-level view linking dysfunctional modules with regulatory RNAs, transcription factors, and candidate therapeutic proteins, while also showing why the two treatments may act through different molecular routes.
-
Sulfachloropyridazine in E. tenella Microbiome Research
2026-09-08
This study integrates 16S rRNA gene sequencing with LC-MS/MS metabolomics to examine how ethanamizuril, sulfachlorpyridazine, and their combination reshape the cecal ecosystem of chickens infected with Eimeria tenella. Its main contribution is a systems-level framework linking anticoccidial treatment with microbial and metabolic responses, while showing that low-dose combination treatment produced limited ecological disruption.